Lower Part of the Graph
Analysis
Stock ID Number: 515 710
ISIN: DE0005157101
SE Code: HNL
Reuters Code: HNLG.DE
Bloomberg Code: HNL GR
Market Segment: Prime Standard
The Hönle share is listed in the following indices
Index (ISIN)
CDAX (DE0008469602)
Prime All Share (DE0007203325)
Technology All Share (DE0008468943)
Prime Industrial (DE0009660282)
Prime IG Advanced Industrial Equipment (DE0007203895)
Payment Authority
M.M. Warburg, Hamburg, Germany
Number of shares
6,062,930 shares of common stock with a par value of 1 Euro per share in the capital stocktal
Capital stock: € 6.062.930
Registered head office
Dr. Hönle AG
Lochhamer Schlag 1
82166 Graefelfing/Munich
Date of Update: 01/09/2020
2020
| Dec 20 |
Hauck & Aufhäuser buy, target 68.50€ Article |
| Dec 20 |
Warburg Research buy, target 65€ Article |
| Aug 20 |
Warburg Research buy, target 65€ Article |
| Aug 20 |
Warburg Research buy, target 66€ Article |
| Aug 20 |
Hauck & Aufhäuser buy, target 68.50€ Article |
| Aug 20 |
Warburg Research buy, target 64€ Article |
| Aug 20 |
Hauck & Aufhäuser buy, target 66€ Article |
| Jun 20 |
Hauck & Aushäuser buy, target 66€ Article |
| May 20 |
Warburg Research buy, target 65€ Article |
| May 20 |
Hauck & Aufhäuser buy, target 51€ Article |
| May 20 |
Hauck & Aufhäuser buy, target 51€ Article |
| Apr 20 |
Warburg Research buy, target 65€ Article |
2019
| Dec 19 |
Warburg Research buy, target 72€ Article |
Disclaimer
The articles and analyses published on our web pages are intended only for informational purposes and do not represent offers for the purchase or selling of securities or other investment instruments. The present data are compiled to the best of our knowledge and in good faith. With regard to future-related statements neither Dr. Hönle AG nor any of the associated companies can assume responsibility for the occurrence of the forecast. Due to changing general economic conditions or other factors beyond the control of Dr. Hönle AG, future results may differ considerably from the forecast. Irrespective of legal obligations for adjusting forecasts, Dr. Hönle AG does not intend to continually update all statements related to the future.